The proposed sale is small relative to market cap and appears to be a routine diversification move following vesting of equity compensation. Monitor for actual Form 4 filings to confirm execution; no immediate read-through for the stock.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $8.77entry
- T+1 · 8d ago +2.39%α +0.03% · $8.98
- T+5 · 4d ago +0.34%α −2.25% · $8.80
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Carlos Nueno, an officer of Teladoc Health, filed a Form 144 notice of intent to sell 29,432 shares of common stock with an approximate market value of $270,774. The shares were acquired through restricted stock vesting events in 2025 and 2026. The filing signals a planned sale but does not confirm execution.
Key Facts
- Carlos Nueno, an officer, filed Form 144 to sell 29,432 shares
- Approximate sale value: $270,774
- Shares acquired through restricted stock vesting from March 2025 to September 2026
- Proposed sale date: November 6, 2026
- The filing is an advance notice of intent to sell; the sale may not occur
Financial Impact
29,432 shares at approximately $270,774, representing about 0.015% of Teladoc's $1.8B market cap
Risk Factors
- The sale may not occur; Form 144 is only an intent to sell
- No context on the officer's remaining holdings or total ownership percentage
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007802 |
| Document: 0001959173-26-007802-index.html | 0001959173-26-007802 |
| Document: 0001959173-26-007802.txt | 0001959173-26-007802 |
Track record
24 reports on TDOC
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +2.52% at T+1 after the Oct 28, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
- Nov 6, 202610d ago 144 Neutral 3/10 Viewing Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
- Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
- Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
- Oct 28, 202619d ago Press Release Bearish 6/10 No price data
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
- Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
- Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
- Sep 11, 20269w ago 144 Neutral 2/10 Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers